# 바이오스페이스 일일 뉴스 리포트 - 2026년 02월 27일


## 주요 헤드라인

1. **After Sarepta’s Annus Horribilis, Elevidys Sales Expected To Continue Downward Spiral (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/after-sareptas-annus-horribilis-elevidys-sales-expected-to-continue-downward-spiral>

2. **After Sarepta’s Annus Horribilis, Elevidys Sales Expected To Continue Downward Spiral (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/after-sareptas-annus-horribilis-elevidys-sales-expected-to-continue-downward-spiral>

3. **ALS Advances Unite Patients and Pharma on Novel Targets, Biomarker Breakthroughs (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/als-advances-unite-patients-and-pharma-on-novel-targets-biomarker-breakthroughs>

4. **Lilly Tops Novo in Weight Loss Again, This Time on the Oral Front (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/lilly-tops-novo-in-weight-loss-again-this-time-on-the-oral-front>

5. **Opinion (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/opinion-new-painkillers-critical-to-fight-opioid-epidemic-broader-pain-crisis>

6. **Opinion (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/opinion-new-painkillers-critical-to-fight-opioid-epidemic-broader-pain-crisis>

7. **Sarepta CEO Doug Ingram To Step Down as Muscular Dystrophy Mission Hits Home (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/sarepta-ceo-doug-ingram-to-step-down-as-muscular-dystrophy-mission-hits-home>


---
*2026년 02월 27일 바이오스페이스 뉴스 피드에서 생성된 리포트*